Jennifer Puck, M.D., an expert on human primary immunodeficiencies at the University of California, San Francisco, spoke on newborn screening to detect immune defects at her recent Flexner Discovery Lecture.
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer.
A five-year study to explore new technologies that automate patient care outside of hospitals and doctors’ offices will identify ways technology can provide real-time feedback and guidance to patients and to alert care coordination teams before health issues escalate.
Jeffrey Sosman, M.D., professor of Medicine and leader of the Vanderbilt Melanoma Program, will head one of two teams of researchers at prominent national institutions investigating acral melanoma, a skin cancer that typically forms on the hands, soles of the feet or under the fingernails.
Just before 3 p.m. on April 15, two bombs exploded at the finish line of the Boston Marathon. Of the estimated 27,000 runners and 500,000 spectators present, three people were killed and 281 injured. Preparation, execution and teamwork — along with a large dose of luck — kept casualties to a minimum, according to Mitchel Harris, M.D., chief of the Orthopaedic Trauma Service at Brigham and Women’s Hospital in Boston.